Low-dose compared with standard-dose m-BACOD chemotherapy for non- Hodgkin's lymphoma associated with human immunodeficiency virus infection Academic Article uri icon

Overview

MeSH Major

  • Antineoplastic Combined Chemotherapy Protocols
  • Granulocyte-Macrophage Colony-Stimulating Factor
  • HIV Infections
  • Lymphoma, Non-Hodgkin

abstract

  • As compared with treatment with standard doses of cytotoxic chemotherapy (m-BACOD), reduced doses caused significantly fewer hematologic toxic effects yet had similar efficacy in patients with HIV-related lymphoma. Dose-modified chemotherapy should be considered for most HIV-infected patients with lymphoma.

publication date

  • June 14, 1997

Research

keywords

  • Academic Article

Identity

Language

  • eng

Digital Object Identifier (DOI)

  • 10.1056/NEJM199706053362304

PubMed ID

  • 9171066

Additional Document Info

start page

  • 1641

end page

  • 8

volume

  • 336

number

  • 23